abstract |
The pharmaceutical composition comprises the additional acid salt of (N) -N - [- phenyl-isopropyl] -n-methyl-1-propynylamine (selegiline) in a therapeutically effective amount and, optionally, one or more neuroleptics and pharmaceutically acceptable carriers and other excipients. |